SYNLOGIC, INC. Income Taxes Paid
SYNLOGIC, INC. (SYBX) reported Income Taxes Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-03-12
- SYNLOGIC, INC. income taxes paid, net for the quarter ending 2025-12-31 was $0.00.
- SYNLOGIC, INC. income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- SYNLOGIC, INC. income taxes paid, net for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. income taxes paid, net for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. income taxes paid, net for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SYNLOGIC, INC. income taxes paid, net for fiscal 2024 was $5.00K, a 64.29% decline from fiscal 2023.
- SYNLOGIC, INC. income taxes paid, net for fiscal 2023 was $14.00K.
- SYNLOGIC, INC. income taxes paid, net for fiscal 2022 was $0.00.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $5.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $5.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $5.00K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $5.00K derived: sum of 2 quarters · filed 2025-03-06 | $14.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $12.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $9.00K 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $0.00 10-K · filed 2024-03-19 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |